Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis

Author:

Chen Xiangjun,Zhang Ying,Cao Zhongkai,Wang Yue,Liao Mengqiu,Guan Yuelin,Zhu Caifeng,Wang Wenmin,Huang Wunan,Li Wei,Xiao Yingping,Li Yayu,Yin Jiazhen,Ding Yuhan,Peng Qinghua,Hu Lidan

Funder

Fundamental Research Funds for the Provincial Universities of Zhejiang Province

Key Research and Development Program of Zhejiang Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference57 articles.

1. International diabetes federation, idf diabetes atlas;Federation ID,2021

2. The global epidemics of diabetes in the 21st century: current situation and perspectives;Standl;Eur. J. Prev. Cardiol.,2019

3. Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in china: a meta-analysis of observational studies;Zhang;J. Diab. Res.,2020

4. Diabetic kidney disease: challenges, progress, and possibilities;Alicic;Clin. J. Am. Soc. Nephrol.,2017

5. The concept and the epidemiology of diabetic nephropathy have changed in recent years;Martínez-Castelao;J.Clin. Med.,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3